Nicodicodeine
From Wikipedia, the free encyclopedia
This article does not cite any sources. (January 2007) (Learn how and when to remove this template message) |
Systematic (IUPAC) name | |
---|---|
(5α,6α)-3-Methoxy-17-methyl-4,5-epoxymorphinan-6-yl nicotinate
|
|
Clinical data | |
Routes of administration |
Oral, intravenous |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 808-24-2 |
ATC code | none |
PubChem | CID 5464304 |
ChemSpider | 4576612 |
Synonyms | 6-Nicotinoyldihydrocodeine |
Chemical data | |
Formula | C24H26N2O4 |
Molar mass | 406.474 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Nicodicodeine is an opioid developed as a cough suppressant and analgesic. Synthesized in 1904, it is not commonly used, but has activity similar to other opioids. Nicodicodeine is metabolised in the liver by demethylation to produce 6-nicotinoyldihydromorphine, and subsequently further metabolised to dihydromorphine. Since the final active metabolite is the slightly stronger opiate dihydromorphine rather than morphine, nicodicodeine can be expected to be marginally more potent and longer acting than nicocodeine. Side effects are similar to those of other opioids and include itching, nausea and respiratory depression.
References[edit]
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |